Repetitive transcranial magnetic stimulation is a non-invasive procedure which accounts for brain health procedure. Procedure involves magnetic stimulation to stimulate nerve cells present in brain to improve symptoms of irregular pulses.
The device comprise of an electromagnetic coil which delivers continuous magnetic pulses to stimulate nerve cells. Repetitive transcranial magnetic stimulation is primarily meant as a non-invasive procedure for treating depression.
Unlike other contemporary solutions like deep brain stimulation and vagus nerve stimulation which are invasive in nature, repetitive transcranial magnetic stimulation comes out to be the most certain of the lot. A session of repetitive transcranial magnetic stimulation typically takes around 30 minutes and is given on consecutive times for optimum results.
The procedure does not require any anaesthetic or sedation and comes as a procedure with minimal effects on brain memory. Standard treatment for depression includes prescribed drugs which are not suitable for most of the cases, but repetitive transcranial magnetic stimulation is suitable in most cases and recommended for patients responding negative to depression drugs.
Repetitive transcranial magnetic stimulation procedure is rarely used for other cases than depression. But cases of depression reported due to social changes is in huge numbers, which gives a clear opportunity for the repetitive transcranial magnetic stimulation manufacturers to build something on this space.
The first FDA approved repetitive transcranial magnetic stimulation device came in October 2008, researchers have found the best solution in order to limit the effects of depression. Studies from functional MRI and EEG shows recording of the repetitive transcranial magnetic stimulation device which triggers same node present in the brain responsible for depression.
Also due to lack of resources and a rising middle class population tends to limit the expensive procedure to cure a mental health problem. Social differences allow very less percentage of affected population to be cured through this procedure, a majority part of people go for medication to cure their mental health issues than sustainable and effective procedure of repetitive transcranial magnetic stimulation.
The market for repetitive transcranial magnetic stimulation is restricted regarding their use, low healthcare expenditure in developing regions, costs considerations, etc. Though, the procedure would significantly decrease global head counts of people suffering from mental health issues like depression.
This if taken into serious account would drastically help those in serious conditions of depression.
The global market for repetitive transcranial magnetic stimulation is consolidated with few players operating in the global space. Market would increase with increase in understanding among patients and manufacturers entering in the market.
Depression leads too many unwanted choices and procedure like this needs to be pushed into the market where it is not present and create a social platform to market these with affordability and positive result.
Geographically, the Repetitive transcranial magnetic stimulation Market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific Excluding China and Japan, Japan, China, Middle East and Africa.
The North America account for a significant market share owing to extensive use of medication and cancer programs being initiated. Additionally, the fastest uptake of new methods in the US drives the repetitive transcranial magnetic stimulation market.
Western Europe is the second largest market in the world due to high income and healthcare penetration. Asia Pacific region is expected to grow rapidly and China and India are likely to lead this market due to fast growing healthcare sector during the forecast period for Repetitive transcranial magnetic stimulation market.
China is expected to take a progressive step in the market for global repetitive transcranial magnetic stimulation market throughout the forecast period due to its reformed healthcare policies and public initiatives to cut down the prevalence rate of indications.
Demographic changes in respective countries show different landscape for repetitive transcranial magnetic stimulation market, where the volume of such procedures is more in developed countries as compare to countries in Latin America and Africa.
Some of the major players in the global repetitive transcranial magnetic stimulation market are The Magstim Company Limited, Medicaid Systems, MAG & More GmbH, and Neuronetics. Technological advancements tend to help emerging the global repetitive transcranial magnetic stimulation market.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Tentatively, the global Repetitive transcranial magnetic stimulation Market has been segmented on the basis of cell type, test type, end user and geography.
Based on Product type, the global repetitive transcranial magnetic stimulation Market is segmented as:
Based on end user, the global repetitive transcranial magnetic stimulation Market is segmented as:
Explore Similar Insights
Repetitive Transcranial Magnetic Stimulation Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
